A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. [electronic resource]
Producer: 20080403Description: 47-58 p. digitalISSN:- 8755-6863
- Administration, Inhalation
- Adolescent
- Adult
- Anti-Bacterial Agents -- administration & dosage
- Aztreonam -- administration & dosage
- Cystic Fibrosis -- complications
- Double-Blind Method
- Female
- Forced Expiratory Flow Rates
- Humans
- Male
- Nebulizers and Vaporizers
- Pseudomonas Infections -- complications
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.